Laughlin Whitney M 4/A

What Happened

• Whitney M. Laughlin, Chief Legal Officer of AMN Healthcare (AMN), had RSUs vest and received a new RSU grant on Jan 15, 2026. A total of 4,488 vested RSUs converted into common shares (no exercise price). Of those, 1,332 shares were withheld/sold to cover tax obligations at $19.55 per share, generating $26,041. Net delivered shares from the vesting were 3,156.
• Separately, Laughlin was granted 19,641 new Restricted Stock Units (RSUs) on Jan 15, 2026 (these are derivative awards that vest over time). This filing is an amendment to correct previously overstated beneficial ownership.

Key Details

• Transaction date: January 15, 2026. Tax-withheld shares sold at $19.55/share (total proceeds $26,041).
• Vesting/conversion: 4,488 RSUs converted to common stock (no cash exercise price). Tax withholding: 1,332 shares withheld.
• New grant: 19,641 RSUs awarded (vest in three tranches over the next 1–3 years per plan terms).
• Shares owned after transaction: Amended Form 4 reports 19,641 securities beneficially owned by the reporting person (corrects prior report that overstated ownership as 39,282).
• Notable footnotes: F1/F2 explain RSU vesting and share withholding for taxes; F9 describes the Jan 15, 2026 RSU grant vesting schedule; F10 explains this is an AMENDED filing to correct the previously reported ownership number.
• Filing: Amended Form 4 filed Jan 30, 2026 to correct prior reporting error (original Form 4 filed Jan 16, 2026 had overstated derivative holdings).

Context

• These transactions are compensation-related (RSU vesting and a new RSU award), not open-market purchases — vesting conversions have $0 exercise price and are routine for executive compensation.
• The company withheld/sold shares to cover taxes (common practice); this is not necessarily a cash sale by the insider expressing a view on the stock.
• The amended filing merely corrects the post-transaction beneficial ownership figure and does not indicate additional trading activity.